Is diabetes a marker of higher risk after carotid revascularization? Experience from a single centre

Renato Casana, Chiara Malloggi, Andrea Odero, Valerio Tolva, Richard Bulbulia, Alison Halliday, Vincenzo Silani

Research output: Contribution to journalArticle

Abstract

Purpose: This single centre study investigates the influence of diabetes mellitus on outcomes following carotid artery endarterectomy or stenting. Methods: In total, 752 carotid revascularizations (58.2% carotid artery stenting and 41.8% carotid endarterectomy) were performed in 221 (29.4%) patients with diabetes and 532 (70.6%) patients without diabetes. The study outcomes were death, disabling and non-disabling stroke, transient ischaemic attack and restenosis within 36 months after the procedure. Results: Patients with diabetes had higher periprocedural risk of any stroke or death (3.6% diabetes vs 0.6% no diabetes; p < 0.05), transient ischaemic attack (1.8% diabetes vs 0.2% no diabetes; p > 0.05) and restenosis (2.7% diabetes vs 0.6% no diabetes; p < 0.05). During long-term follow-up, there were no significant differences in Kaplan–Meier estimates of freedom from death, any stroke and transient ischaemic attack, between people with and without diabetes for each carotid artery stenting and carotid endarterectomy subgroup. Patients with diabetes showed higher rates of restenosis during follow-up than patients without diabetes (36-months estimate risk of restenosis: 21.2% diabetes vs 12.5% no diabetes; p < 0.05). Conclusion: The presence of diabetes was associated with increased periprocedural risk, but no further additional risk emerged during longer term follow-up. Restenosis rates were higher among patients with diabetes.

Original languageEnglish
Pages (from-to)314-321
Number of pages8
JournalDiabetes and Vascular Disease Research
Volume15
Issue number4
DOIs
Publication statusPublished - Jul 1 2018

Fingerprint

Carotid Endarterectomy
Carotid Arteries
Stroke
Transient Ischemic Attack
Diabetes Mellitus
Outcome Assessment (Health Care)

Keywords

  • carotid endarterectomy
  • Diabetes mellitus
  • restenosis
  • stenting

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this

Is diabetes a marker of higher risk after carotid revascularization? Experience from a single centre. / Casana, Renato; Malloggi, Chiara; Odero, Andrea; Tolva, Valerio; Bulbulia, Richard; Halliday, Alison; Silani, Vincenzo.

In: Diabetes and Vascular Disease Research, Vol. 15, No. 4, 01.07.2018, p. 314-321.

Research output: Contribution to journalArticle

@article{c5d3e79b709e4296a7540760b69f31d2,
title = "Is diabetes a marker of higher risk after carotid revascularization? Experience from a single centre",
abstract = "Purpose: This single centre study investigates the influence of diabetes mellitus on outcomes following carotid artery endarterectomy or stenting. Methods: In total, 752 carotid revascularizations (58.2{\%} carotid artery stenting and 41.8{\%} carotid endarterectomy) were performed in 221 (29.4{\%}) patients with diabetes and 532 (70.6{\%}) patients without diabetes. The study outcomes were death, disabling and non-disabling stroke, transient ischaemic attack and restenosis within 36 months after the procedure. Results: Patients with diabetes had higher periprocedural risk of any stroke or death (3.6{\%} diabetes vs 0.6{\%} no diabetes; p < 0.05), transient ischaemic attack (1.8{\%} diabetes vs 0.2{\%} no diabetes; p > 0.05) and restenosis (2.7{\%} diabetes vs 0.6{\%} no diabetes; p < 0.05). During long-term follow-up, there were no significant differences in Kaplan–Meier estimates of freedom from death, any stroke and transient ischaemic attack, between people with and without diabetes for each carotid artery stenting and carotid endarterectomy subgroup. Patients with diabetes showed higher rates of restenosis during follow-up than patients without diabetes (36-months estimate risk of restenosis: 21.2{\%} diabetes vs 12.5{\%} no diabetes; p < 0.05). Conclusion: The presence of diabetes was associated with increased periprocedural risk, but no further additional risk emerged during longer term follow-up. Restenosis rates were higher among patients with diabetes.",
keywords = "carotid endarterectomy, Diabetes mellitus, restenosis, stenting",
author = "Renato Casana and Chiara Malloggi and Andrea Odero and Valerio Tolva and Richard Bulbulia and Alison Halliday and Vincenzo Silani",
year = "2018",
month = "7",
day = "1",
doi = "10.1177/1479164118769530",
language = "English",
volume = "15",
pages = "314--321",
journal = "Diabetes and Vascular Disease Research",
issn = "1479-1641",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Is diabetes a marker of higher risk after carotid revascularization? Experience from a single centre

AU - Casana, Renato

AU - Malloggi, Chiara

AU - Odero, Andrea

AU - Tolva, Valerio

AU - Bulbulia, Richard

AU - Halliday, Alison

AU - Silani, Vincenzo

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Purpose: This single centre study investigates the influence of diabetes mellitus on outcomes following carotid artery endarterectomy or stenting. Methods: In total, 752 carotid revascularizations (58.2% carotid artery stenting and 41.8% carotid endarterectomy) were performed in 221 (29.4%) patients with diabetes and 532 (70.6%) patients without diabetes. The study outcomes were death, disabling and non-disabling stroke, transient ischaemic attack and restenosis within 36 months after the procedure. Results: Patients with diabetes had higher periprocedural risk of any stroke or death (3.6% diabetes vs 0.6% no diabetes; p < 0.05), transient ischaemic attack (1.8% diabetes vs 0.2% no diabetes; p > 0.05) and restenosis (2.7% diabetes vs 0.6% no diabetes; p < 0.05). During long-term follow-up, there were no significant differences in Kaplan–Meier estimates of freedom from death, any stroke and transient ischaemic attack, between people with and without diabetes for each carotid artery stenting and carotid endarterectomy subgroup. Patients with diabetes showed higher rates of restenosis during follow-up than patients without diabetes (36-months estimate risk of restenosis: 21.2% diabetes vs 12.5% no diabetes; p < 0.05). Conclusion: The presence of diabetes was associated with increased periprocedural risk, but no further additional risk emerged during longer term follow-up. Restenosis rates were higher among patients with diabetes.

AB - Purpose: This single centre study investigates the influence of diabetes mellitus on outcomes following carotid artery endarterectomy or stenting. Methods: In total, 752 carotid revascularizations (58.2% carotid artery stenting and 41.8% carotid endarterectomy) were performed in 221 (29.4%) patients with diabetes and 532 (70.6%) patients without diabetes. The study outcomes were death, disabling and non-disabling stroke, transient ischaemic attack and restenosis within 36 months after the procedure. Results: Patients with diabetes had higher periprocedural risk of any stroke or death (3.6% diabetes vs 0.6% no diabetes; p < 0.05), transient ischaemic attack (1.8% diabetes vs 0.2% no diabetes; p > 0.05) and restenosis (2.7% diabetes vs 0.6% no diabetes; p < 0.05). During long-term follow-up, there were no significant differences in Kaplan–Meier estimates of freedom from death, any stroke and transient ischaemic attack, between people with and without diabetes for each carotid artery stenting and carotid endarterectomy subgroup. Patients with diabetes showed higher rates of restenosis during follow-up than patients without diabetes (36-months estimate risk of restenosis: 21.2% diabetes vs 12.5% no diabetes; p < 0.05). Conclusion: The presence of diabetes was associated with increased periprocedural risk, but no further additional risk emerged during longer term follow-up. Restenosis rates were higher among patients with diabetes.

KW - carotid endarterectomy

KW - Diabetes mellitus

KW - restenosis

KW - stenting

UR - http://www.scopus.com/inward/record.url?scp=85046825122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046825122&partnerID=8YFLogxK

U2 - 10.1177/1479164118769530

DO - 10.1177/1479164118769530

M3 - Article

VL - 15

SP - 314

EP - 321

JO - Diabetes and Vascular Disease Research

JF - Diabetes and Vascular Disease Research

SN - 1479-1641

IS - 4

ER -